FDA.reportPublic FDA data

PORE REFINING SERUM

Manufacturer
Yiwu Ziqiu Import Export Co Ltd
Effective date
2024-12-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:42:21

Label at a glance#

ProductPORE REFINING SERUM
Active ingredientNIACINAMIDE
Label structure11 sections

Label contents#

Full prescribing information#

COMPONENTS

Salicylic acid 2%

OTC - PURPOSE SECTION

wart remover

INDICATIONS & USAGE SECTION

Apply twice daly(moring and night as a man and once as a woman.Afer apicaion, proeed with an acive masage for 3-5 minutes unthe product is fuy absorbed

WARNINGS SECTION

Forevemaluseony Avoid coniac wth eves li coniac ocus nse ihorouthly wt waier Keep out ofreach oi chidrenifvou ale preanant.nursing. otiaveanyunderving medca condion.consutyou healthcare provider before using the product

DOSAGE & ADMINISTRATION SECTION

For external use only.

OTC - DO NOT USE SECTION

Discontinue use if any irritation or adverse reaction occurs

OTC - WHEN USING SECTION

When using this product, avoid contact with eyes. lf contact occurs, rinse thoroughly with waterDiscontinue use if any irritation or adverse reaction occurs.

OTC - STOP USE SECTION

on broken or irritated scalp

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If sxralowed, get medical help or contact a Poison Conirol Cenler ngiht away.

INACTIVE INGREDIENT SECTION

Acrylates copolymer, Ethyl acetate

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelLabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
84756-870-012024-12-23C16284748780-129f3f9da-59d7-8323-e063-dbdaa90a1b6729106725-e98b-8230-e063-6394a90a468d
84756-870-022024-12-23C16284748780-129f3f9da-59d7-8323-e063-dbdaa90a1b6729106725-e98b-8230-e063-6394a90a468d
84756-870-032024-12-23C16284748780-129f3f9da-59d7-8323-e063-dbdaa90a1b6729106725-e98b-8230-e063-6394a90a468d
84756-870-042024-12-23C16284748780-129f3f9da-59d7-8323-e063-dbdaa90a1b6729106725-e98b-8230-e063-6394a90a468d
84756-870-052024-12-23C16284748780-129f3f9da-59d7-8323-e063-dbdaa90a1b6729106725-e98b-8230-e063-6394a90a468d

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84756-870-01PORE REFINING SERUM5 mL in 1 BOTTLELIQUID51
84756-870-02PORE REFINING SERUM15 mL in 1 BOTTLELIQUID151
84756-870-03PORE REFINING SERUM30 mL in 1 BOTTLELIQUID301
84756-870-04PORE REFINING SERUM50 mL in 1 BOTTLELIQUID501
84756-870-05PORE REFINING SERUM100 mL in 1 BOTTLELIQUID1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84756-870PORE REFINING SERUM LIQUID [YIWU ZIQIU IMPORT EXPORT CO LTD]15 package rows20241213_29106725-e98b-8230-e063-6394a90a468d.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84756-87084756-870-01, 84756-870-02, 84756-870-03, 84756-870-04, 84756-870-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
NameUNIIKind
GLYCERINPDC6A3C0OXIACT
NIACINAMIDE25X51I8RD4ACTIB
PALMITOYL PENTAPEPTIDE-4KK181SM5JGIACT
SESAME OILQX10HYY4QVIACT
PALMITOYL TRIPEPTIDE-1RV743D216MIACT
CHLORPHENESINI670DAL4SZIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
29106725-e98c-8230-e063-6394a90a468d29106725-e98b-8230-e063-6394a90a468d2024-12-12WarningsExact identifier
spl id: 29106725-e98c-8230-e063-6394a90a468d
spl set id: 29106725-e98b-8230-e063-6394a90a468d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.